Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 4Completed 3Withdrawn 2Terminated 2Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Stomach Neoplasms 2Uterine Cervical Neoplasms 1Pancreatic Neoplasms 1Liver Neoplasms 1Gallbladder Neoplasms 1Esophageal Neoplasms 1Colonic Neoplasms 1Breast Neoplasms 1Biliary Tract Neoplasms 1

Interventions

Cyclophosphamide 77Docetaxel 69Capecitabine 64Trastuzumab 61Paclitaxel 50Tamoxifen 47Epirubicin 47Letrozole 44pyrotinib 40Fulvestrant 37Doxorubicin 35Vinorelbine 33Radiotherapy 32Carboplatin 32Anastrozole 28exemestane 27Neoadjuvant Therapy 24Drug Therapy 22Fluorouracil 21palbociclib 20Exercise 20Chemotherapy, Adjuvant 19Bevacizumab 18pertuzumab 16Goserelin 16Cisplatin 16liposomal doxorubicin 15Mammography 14Gemcitabine 14Blood Specimen Collection 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Breast Neoplasms × taxane × Clear all
NCT02441933 2024-06-04

Carboplatin in EARLY Triple Negative Breast Cancer Trial (PEARLY Trial)

Yonsei University

Phase 3 Unknown
878 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡